Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Noble Romans (NROM) Research & Development (2016 - 2018)

Noble Romans (NROM) has 8 years of Research & Development data on record, last reported at $26368.0 in Q4 2018.

  • For Q4 2018, Research & Development rose 5.64% year-over-year to $26368.0; the TTM value through Dec 2018 reached $102883.0, down 39.83%, while the annual FY2018 figure was $102883.0, 39.83% down from the prior year.
  • Research & Development reached $26368.0 in Q4 2018 per NROM's latest filing, up from $23945.0 in the prior quarter.
  • Across five years, Research & Development topped out at $83427.0 in Q4 2015 and bottomed at $21939.0 in Q1 2018.
  • Average Research & Development over 4 years is $46862.1, with a median of $48134.0 recorded in 2017.
  • The widest YoY moves for Research & Development: up 39.9% in 2017, down 67.75% in 2017.
  • A 4-year view of Research & Development shows it stood at $83427.0 in 2015, then fell by 7.22% to $77407.0 in 2016, then tumbled by 67.75% to $24961.0 in 2017, then rose by 5.64% to $26368.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Research & Development were $26368.0 in Q4 2018, $23945.0 in Q3 2018, and $30631.0 in Q2 2018.